Clinical Trial Update: Different Reversal Agents in Pediatric Day-case Cancer Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing different reversal agents in pediatric day-case cancer surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-operative Residual Curarization

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Post-operative Residual Curarization | Phase 4 | Status: UNKNOWN